Use of thromboelastography to guide thromboprophylaxis after caesarean section

被引:15
作者
Boyce, H. [1 ]
Hume-Smith, H. [1 ]
Ng, J. [1 ]
Columb, M. O. [2 ]
Stocks, G. M. [1 ]
机构
[1] Queen Charlottes & Chelsea Hosp, Dept Anaesthesia, London W6 0XG, England
[2] Wythenshawe Hosp, Univ S Manchester Hosp, Dept Anaesthesia, Manchester M23 9LT, Lancs, England
关键词
Obstetric anaesthesia; Thromboelastography; Thromboprophylaxis; Heparin; Caesarean section; MOLECULAR-WEIGHT HEPARIN; SUBCUTANEOUS UNFRACTIONATED HEPARIN; OBSTETRIC THROMBOPROPHYLAXIS; LIVER-TRANSPLANTATION; HEALTHY PARTURIENTS; POSTPARTUM PERIOD; RISK-FACTORS; XA ACTIVITY; PREGNANCY; THROMBELASTOGRAPHY;
D O I
10.1016/j.ijoa.2011.03.006
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Thromboprophylaxis is commonly required following caesarean section. However the effect of thromboprophylactic dosages of subcutaneous heparin on coagulation is unknown because conventional laboratory tests are largely unaffected. The aim of this study was to determine if thromboelastography could detect and quantify the effect of unfractionated heparin on coagulation profile when given at the time of surgery. Methods: Nineteen women undergoing elective caesarean section were recruited. Blood samples collected before and after administration of subcutaneous unfractionated heparin 7500 IU underwent thromboelastography using both plain and heparinase cuvettes. Anti-factor Xa levels were also measured. Results: There was a significant difference in R times between plain and heparinase samples (-10.6%, P = 0.0072) indicating that thromboelastography could detect an effect of unfractionated heparin. Compared to baseline there were significant decreases of R times in plain (-20.4%, P = 0.033) and heparinase (-28.8%, P = 0.0001) samples despite the administration of unfractionated heparin. Anti-factor Xa levels were virtually undetectable (mean 0.01 U/mL). Conclusion: Thromboelastography was able to detect and quantify the effect of unfractionated heparin on blood coagulability, an effect not detected by conventional laboratory tests. Thromboelastography demonstrated a pro-coagulant effect of surgery that was only partially mitigated by the use of unfractionated heparin. In this study, at a dose of 7500 IU subcutaneous unfractionated heparin appears to have little anticoagulant effect. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 31 条
  • [1] [Anonymous], 2007, 7 REPORT CONFIDENTIA
  • [2] Heparin levels to guide thromboembolism prophylaxis during pregnancy
    Barbour, LA
    Smith, JM
    Marlar, RA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (06) : 1869 - 1873
  • [3] Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery
    Boer, K.
    den Hollander, I. A.
    Meijers, J. C. M.
    Levi, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (12) : 2415 - 2420
  • [4] Low molecular weight heparin for thromboprophylaxis during caesarean section
    Bonnar, J
    Norris, LA
    Greene, R
    [J]. THROMBOSIS RESEARCH, 1999, 96 (04) : 317 - 322
  • [5] PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS HEPARIN DURING THE EARLY 3RD TRIMESTER OF PREGNANCY
    BRANCAZIO, LR
    ROPERTI, KA
    STIERER, R
    LAIFER, SA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) : 1240 - 1245
  • [6] Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs
    Butwick, A. J.
    Carvalho, B.
    [J]. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2010, 19 (02) : 193 - 201
  • [7] Butwick A, 2007, CAN J ANAESTH, V54, P190, DOI 10.1007/BF03022639
  • [8] *CAES SECT, 2004, CLIN GUID COMM NAT I
  • [9] Thrombelastography monitoring of resistance to enoxaparin anticoagulation in thrombophilic pregnancy patients
    Carroll, Roger C.
    Craft, Robert M.
    Whitaker, Gregory L.
    Snider, Carolyn C.
    Kirby, Ryan K.
    Elder, Robert F.
    Hennessey, Mark D.
    [J]. THROMBOSIS RESEARCH, 2007, 120 (03) : 367 - 370
  • [10] Chunilal SD, 2002, THROMB HAEMOSTASIS, V87, P92